---
title: 'The cost of slow biosimilar uptake in the US: an Infliximab case study'
image: images/writing/post-16.jpg
link: https://www.pharmaceutical-technology.com/comment/biosimilar-uptake-infliximab/
categories:
- Analyst Insight

---
